Literature DB >> 15162299

Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.

I Mantel1, M A Brantley, C Bellmann, A G Robson, G E Holder, A Taylor, G Anderson, A T Moore.   

Abstract

BACKGROUND: The neuronal ceroid lipofuscinoses (Batten disease) are a heterogeneous group of autosomal recessively inherited disorders causing progressive neurological failure, mental deterioration, seizures and visual loss secondary to retinal dystrophy. The juvenile type is of special interest to the ophthalmologist as visual loss is the earliest symptom of the disorder. HISTORY AND SIGNS: We present two siblings with severe retinal dystrophy due to juvenile Batten disease. Sibling A (age 10) presented with visual loss, photophobia and night blindness, starting at age 4. His vision was perception of light by the age of 10.5 years. Fundus examination revealed severe pigmentary retinopathy. Sibling B (age 7) presented with night vision difficulties. Fundus examination revealed a bull's eye maculopathy with minimal peripheral atrophic changes. In vivo autofluorescence level was found to be very low. Electroretinography (ERG) showed generalized retinal dysfunction involving both cone and rod systems, with an electronegative maximal response. In both siblings vacuolated lymphocytes were found on a peripheral blood film and on molecular genetic testing both were homozygous for the commonly reported 1.02-kb deletion of the CLN3 gene. THERAPY AND OUTCOME: Although there is no effective treatment, the early diagnosis allowed accurate genetic and social counseling.
CONCLUSIONS: Juvenile Batten disease should be considered in children with a retinal dystrophy, especially where there is a bull's eye maculopathy and an abnormal full field ERG. The novel finding of very low in vivo autofluorescence is consistent with histopathological studies and may be secondary to photoreceptor cell loss.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15162299     DOI: 10.1055/s-2004-812819

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  5 in total

1.  [Juvenile neuronal ceroid lipofuscinosis. Ophthalmologic findings and differential diagnosis].

Authors:  T U Krohne; P Herrmann; J Kopitz; K Rüther; F G Holz
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Batten disease: features to facilitate early diagnosis.

Authors:  J Collins; G E Holder; H Herbert; G G W Adams
Journal:  Br J Ophthalmol       Date:  2006-06-05       Impact factor: 4.638

Review 3.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

4.  Juvenile Batten Disease (CLN3): Detailed Ocular Phenotype, Novel Observations, Delayed Diagnosis, Masquerades, and Prospects for Therapy.

Authors:  Genevieve A Wright; Michalis Georgiou; Anthony G Robson; Naser Ali; Ambreen Kalhoro; Sm Kleine Holthaus; Nikolas Pontikos; Ngozi Oluonye; Emanuel R de Carvalho; Magella M Neveu; Richard G Weleber; Michel Michaelides
Journal:  Ophthalmol Retina       Date:  2019-11-13

5.  Batten's Disease: A Seizure Disorder's Battle for Diagnosis.

Authors:  Nishanth Dev; Rahul Kumar; Shruti Sharma; M C Sharma
Journal:  Ann Indian Acad Neurol       Date:  2021-01-25       Impact factor: 1.383

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.